Lp(a) testing and treatment with Lp(a)-lowering therapies in the primary and secondary prevention of cardiovascular disease in high income countries: A preliminary health technology assessment
{{output}}
Background and aims: New therapies targeting Lipoprotein(a) (Lp(a)) are anticipated to enter clinical practice soon. We aimed to estimate the benefits of Lp(a) lowering therapy and threshold price at which treatment with Lp(a)-lo... ...
